Cite
Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design
MLA
L. A. Daamen, et al. “Recurrent Disease Detection after Resection of Pancreatic Ductal Adenocarcinoma Using a Recurrence-Focused Surveillance Strategy (RADAR-PANC): Protocol of an International Randomized Controlled Trial According to the Trials within Cohorts Design.” Trials, vol. 25, no. 1, June 2024, pp. 1–18. EBSCOhost, https://doi.org/10.1186/s13063-024-08223-5.
APA
L. A. Daamen, I. W. J. M. van Goor, V. P. Groot, P. C. M. Andel, L. A. A. Brosens, O. R. Busch, G. A. Cirkel, N. Haj Mohammad, H. D. Heerkens, I. H. J. T. de Hingh, F. Hoogwater, H. W. M. van Laarhoven, M. Los, G. J. Meijer, V. E. de Meijer, R. Pande, K. J. Roberts, J. Stoker, M. W. J. Stommel, … for the Dutch Pancreatic Cancer Group. (2024). Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design. Trials, 25(1), 1–18. https://doi.org/10.1186/s13063-024-08223-5
Chicago
L. A. Daamen, I. W. J. M. van Goor, V. P. Groot, P. C. M. Andel, L. A. A. Brosens, O. R. Busch, G. A. Cirkel, et al. 2024. “Recurrent Disease Detection after Resection of Pancreatic Ductal Adenocarcinoma Using a Recurrence-Focused Surveillance Strategy (RADAR-PANC): Protocol of an International Randomized Controlled Trial According to the Trials within Cohorts Design.” Trials 25 (1): 1–18. doi:10.1186/s13063-024-08223-5.